← brief for 2026-10-14 · Slowing decline

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

Trial No results yet Not peer reviewed

Key takeaways

This is a study that is starting in Spain. It will watch how a drug called finerenone works in people with kidney disease and type 2 diabetes. It will track their risk of getting worse. There are no results yet because the study is just beginning.

Who did this work

Run by Bayer.
Sites: Many locations

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-10-14
https://clinicaltrials.gov/study/NCT07554469